FDA’s Gottlieb: Any FDA/CMS Collaboration Efforts Should Occur Postmarket

FDA and CMS should streamline their internal review processes before pursuing collaborative efforts to avoid an overly burdensome review process, according to FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD